Core Viewpoint - A class action lawsuit has been filed against LifeMD, Inc. for allegedly overstating its competitive position and failing to account for rising customer acquisition costs, leading to a significant drop in share value [1][3]. Company Overview - LifeMD, Inc. is a direct-to-consumer telehealth company based in New York, providing virtual healthcare services and pharmacy offerings in areas such as men's health, obesity treatment, and chronic care [2]. Legal Action Details - The lawsuit is on behalf of investors who purchased LifeMD shares between May 7, 2025, and August 5, 2025, with a deadline of October 27, 2025, for investors to seek lead plaintiff status [1][2]. - The complaint claims that LifeMD raised its 2025 guidance recklessly, which contributed to the misrepresentation of its financial health [3]. Financial Impact - Following the revelation of the company's financial issues, LifeMD shares experienced a dramatic decline, losing 44% of their value in a single trading session [3].

Core Viewpoint - Albertsons reported solid fourth-quarter results, but the forward outlook for profits was below analyst expectations, leading to an 8% drop in stock price [1][4]. Financial Performance - In the fourth quarter, Albertsons' revenue grew 2.5% to $18.8 billion, supported by a 2.3% increase in same-store sales, which met expectations [3]. - Adjusted earnings per share (EPS) fell 15% to $0.46, surpassing analyst expectations of $0.41 [3]. - The full-year 2025 EPS guidance of $2.03 to $2.16 per share was disappointing, as it was below the expected $2.28, marking the third consecutive year of adjusted earnings declines [4]. Business Strategy and Market Position - The pharmacy segment contributed significantly to revenue growth, while investments in delivery and digital programs increased by 24% last quarter [5]. - However, the pharmacy revenue is lower-margin, and the delivery growth required further investments, which pressured gross margins [5]. - Albertsons is in a challenging competitive position following the rejection of its proposed takeover by Kroger last year [7]. Management Changes - CEO Vivek Sankaran is set to retire on May 1, with COO Susan Morris taking over, which may have influenced the conservative guidance provided by management [2][6].